Felix E deJongh (Felix E de Jongh)

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Positive Breast Cancer

Gene Expression

Sentinel Lymph Node

Top Venues

Journal of medical economics

This page only lists publications with an associated author ORCID identifier.

Publications

Martijn J H G Simons, Peter M Machielsen, Jelle A Spoorendonk, Tim Ignacio, Pieter B Drost, Tim Jacobs, Felix E deJongh
A cost-consequence model of using the 21-gene assay to identify patients with early-stage node-positive breast cancer who benefit from adjuvant chemotherapy in the Netherlands. Journal of medical economics 27 (1) (2024)
Martijn J H G Simons, Peter M Machielsen, Jelle A Spoorendonk, Tim Ignacio, Pieter B Drost, Tim Jacobs, Felix E deJongh
A cost-consequence model of using the 21-gene assay to identify patients with early-stage node-positive breast cancer who benefit from adjuvant chemotherapy in the Netherlands. Journal of medical economics (2024)
Martijn J H G Simons, Peter M Machielsen, Jelle A Spoorendonk, Tim Ignacio, Pieter B Drost, Tim Jacobs, Felix E deJongh
A cost-consequence model of using the 21-gene assay to identify patients with early-stage node-positive breast cancer who benefit from adjuvant chemotherapy in the Netherlands. Journal of medical economics 27 (1) (2024)